AVLAYAH FDA approval date

The FDA approved AVLAYAH on 24 Mar 2026.

FDA approval date
24 Mar 2026

Drug identity has not yet been verified against registry records

Also recorded as TIVIDENOFUSP ALFA-EKNM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-03-24DayAVLAYAHFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761485", "applicant_as_listed_by_fda": "DENALI THERAPEUTICS INC.", "brand_names": ["AVLAYAH"], "active_ingredients": ["TIVIDENOFUSP ALFA-EKNM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260324", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026